Topline data were announced from a phase 3 trial evaluating gefurulimab in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis.

DEAR DR. ROACH: My husband woke up with double vision about three weeks ago. It appears that his left eye is turned inward ...

An optometrist has prescribed prism glasses, which help a little. He’s been wearing an eye patch to drive short distances.

Dear Dr. Roach: My husband woke up with double vision about three weeks ago. It appears that his left eye is turned inward and does not move with his right eye. He's had a prescription for prednisone ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Education about immune-related adverse events associated with checkpoint inhibitor therapy for cancer is essential for every ...

My husband woke up with double vision about three weeks ago. It appears that his left eye is turned inward and does not move with his right eye. He’s had a prescription for prednisone that did not ...

For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or ...

In a significant medical milestone, a specialized team at the new Zarqa Government Hospital successfully performed a complex spinal decompression surgery at two lumbar levels, between the third and ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2025 and reviewed recent ...

Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its ...